Bohm M, Luger TA, Tobin DJ, Garcia-Borron JC
These studies prompted the European Medicines Agency to classify NAION as a very rare side effect requiring label warnings in June 2025, followed by the World Health Organizations safety alert, while the FDA has yet to mandate similar warnings despite mounting evidence
It brings in new risks, such as: Germs in your medicine The medicine is not working at all Unknown long-term problems These new risks can cancel out the notion that being small makes it safer
Each batch is supported by analytical testing methods including HPLC and mass spectrometry to help confirm identity, purity, and consistency
In 1969, Woodstock proved an unexpected natural experiment in competing rewards
Newborn Wistar rats (males only in the experimental phase were included) were separated from the dam for 3 h/day from postnatal day 19, and subsequently treated orally with quercetin or QNP at 10 or 40 mg/kg/day for 21 days starting at Post Natal Day (PND)